Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Mar 24, 2021 10:45am
216 Views
Post# 32866038

WOW! WOW!WOW!

WOW! WOW!WOW!

25 MILLION test strips per month by NanoComposix .....as stated by Rob in his interview. Injection moulded casings would be easy to source as would the sponge samplers. Except under exceptional  circumstances who could be selling their shares right now.

Not wanting to reach too far ahead yet .....but even if they can't source another lab to make test strips .....if this device sells for $5.00 (this is the cheapest rapid antigen test I could find) .....that's $1 billion in sales over an 8 month time period.

Is there a market for that many test strips .....YES! Just this morning there were doctors on CBC radio stating that rapid antigen tests are the only way to get us back on the track to "normal".

Imho, even Morningstar's 1-star speculative valuation of $2.71 is no longer an unreasonable expectation or target.

Great news and a great interview by Rob Fia.

GLTE!!!



 

<< Previous
Bullboard Posts
Next >>